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A B S T R A C T
Cell senescence is an important driver of the ageing process. The accumulation of senescent cells in tissues is
accelerated by stress signals from senescent cells that induce DNA damage and ultimately senescence in by-
stander cells. We examine here the interplay of senescence-associated mitochondrial dysfunction
(SAMD)—driven production of reactive oxygen species (ROS) and senescence-associated secretory phenotype
(SASP) in causing the bystander effect. We show that in various modes of fibroblast senescence ROS are ne-
cessary and sufficient to activate the transcription factor nuclear factor kappa-light-chain-enhancer of activated
B cells (NF-κB), which facilitates a large part of the SASP. This ROS-NF-κB axis causes the DNA damage response
in bystander cells. Cytokines IL-6 and IL-8 are major components of the pro-inflammatory SASP in senescent
fibroblasts. However, their activation in senescence is only partially controlled by NF-κB, and they are thus not
strong candidates as intercellular mediators of the bystander effect as mediated by the ROS-NF-κB axis.
1. Introduction
It is becoming increasingly clear that cell senescence is an important
cause of the loss of tissue functionality and homeostatic capacity that
characterizes ageing. Senescent cells accumulate in many, if not all,
tissues with age (Dimri et al., 1995; Herbig et al., 2006; Jurk et al.,
2012; Wang et al., 2009). In mice, the rate of this accumulation predicts
mean and maximum lifespan of animals over an almost threefold dif-
ference in life expectancy between slow- and fast-ageing cohorts (Jurk
et al., 2014). Selective ablation of senescent cells postponed the de-
velopment of age-associated tissue dysfunction/disease and extended
mean lifespan in mice (Baker et al., 2016, 2011). Drugs like rapamycin,
which extend life expectancy in mice, have been shown to be seno-
statics, i.e. suppressors of multiple aspects of the senescent phenotype
(Correia-Melo et al., 2016). First experimental drugs that selectively kill
senescent cells have been developed and show encouraging results in a
number of mouse models of age-related diseases (Roos et al., 2016;
Schafer et al., 2017; Zhu et al., 2015).
An important role of cell senescence in ageing should not come as a
surprise. After all, cell senescence is a major response to stress and
molecular damage. While it was originally regarded only as a con-
sequence of ongoing cell division and associated telomere loss, seminal
work from Toussaint and others soon showed that both telomere-de-
pendent and independent senescence can be induced by DNA-damaging
stress (Toussaint et al., 2000; von Zglinicki et al., 1995) acting via the
by now well-defined DNA damage response (DDR) pathway (d’Adda di
Fagagna et al., 2003). As was predicted early (von Zglinicki et al.,
2005), the distinction between telomere-dependent (replicative) and
telomere-independent stress-induced senescence became more and
more blurred with data showing stress-related telomere loss as pre-
dictor of transition to senescence at the single cell level (Passos et al.,
2007) as well as the defining role for telomere damage without telo-
mere loss for senescence in mouse cells in vitro and in vivo (Hewitt
et al., 2012; Jurk et al., 2014). Moreover, cell senescence is also the
response to stresses that are not primarily genotoxic but impact pre-
ferentially on the proteome (Castro et al., 2012) or the mitochondrion
(Miwa et al., 2014; Wiley et al., 2016).
In addition to being a stress response, cell senescence is itself an
inducer of stress in the tissues and organisms harbouring senescent
cells. This is because of three important properties of senescent cells: i)
Senescent cells cannot proliferate. Accordingly, senescence of stem and
progenitor cells limits the regenerative potential of tissues and organ-
isms. ii) Senescent cells hyper-produce and secrete a host of bioactive
peptides (the so-called Senescence-Associated Secretory Phenotype
SASP), prominently including pro-inflammatory cytokines like IL-1, IL-
6 and IL-8 under control of the transcription factor NF-κB (Coppe et al.,
2008). These not only stabilize senescence in an autocrine fashion
(Acosta et al., 2008; Kuilman et al., 2008) but may also be a significant
cause of age-related chronic sterile inflammation and contribute to
bystander effects, i.e. enhanced tumorigenicity of transformed cells
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(Krtolica et al., 2001) and induction of DNA damage and senescence in
normal bystander cells (Nelson et al., 2012). iii) The activated DDR in
senescent cells also causes Senescence-Associated Mitochondrial Dys-
function (SAMD), i.e. loss of mitochondrial membrane potential, de-
creased respiratory coupling and increased ROS production, all asso-
ciated with failing mitophagy (Dalle Pezze et al., 2014; Korolchuk et al.,
2017; Passos et al., 2010). Importantly, if mitochondria were selectively
and specifically obliterated in senescent cells, ROS levels returned to
normal, indicating SAMD rather than extra-mitochondrial mechanisms
as the major source of elevated cellular ROS in senescence (Correia-
Melo et al., 2016). As for SASP, SAMD initiates an autocrine positive
feedback loop that enhances ROS-mediated nuclear DNA damage and
thus stabilizes senescence (Passos et al., 2010). In its turn, ROS release
from senescent cells contributes to senescence induction in bystander
cells (Nelson et al., 2012). Finally, SAMD appears as a cause for me-
tabolic insufficiencies in ageing organisms (Ogrodnik et al., 2017).
To understand better how senescent cells contribute to ageing, it
will be necessary to dissect how these two major senescent phenotypes,
SAMD and SASP, interact. It is clear that the two can influence each
other: Short telomeres do not only cause senescence in late generation
telomerase knockout mice (Choudhury et al., 2007), they also induce
widespread inflammation (Jurk et al., 2014). Conversely, chronic in-
flammation in mice null for the repressor p50 subunit of NF-κB ag-
gravates ROS production and senescence (Jurk et al., 2014).
To further assess the interaction between SASP and SAMD, we
treated human fibroblasts in various modes of senescence with either
antioxidants or NF-κB inhibitors and monitored the effects on the cor-
responding phenotype. We also analyzed the relative efficiencies to
induce a DDR in bystander cells under SASP- vs SAMD-inhibition. We
found that antioxidants suppress activation of NF-κB, while suppression
of NF-κB did not reduce SAMD in multiple senescence modes. Both
scavenging of ROS and inhibition of NF-κB blocked the bystander effect.
We conclude that SAMD is an important inducer of the pro-in-
flammatory SASP, which then mediates the bystander effect.
2. Results
2.1. SAMD-derived ROS control SASP but SASP does not control SAMD
There has been sometimes contradictory discussion about the im-
pact of factors such as mode of senescence induction, cell strain, mi-
tochondrial (dys-)function, etc. on SASP composition and potential
downstream bystander effects. We therefore tested the interaction be-
tween SASP and SAMD in multiple human fibroblast systems, using two
independent cell strains (MRC5 and IMR90) and three different modes
of senescence. Cellular senescence was induced via either proliferative
exhaustion (replicative senescence in MRC5, ‘RS'), IR stress-induced
senescence (20 Gy X-ray irradiation in MRC5 and IMR90, ‘IR') or on-
cogene induced senescence (Ras induction in a stably transfected
IMR90 cell line, ' + RAS'). Successful induction of senescence was
confirmed by reduction of growth to less than 10% of controls, senes-
cent morphology and Sen-β-Gal positivity in at least 80% of the cells
(data not shown). NF-κB activity was measured as the relative nuclear/
cytoplasmic intensity of the immunofluorescence signal from the pre-
dominant NF-κB transcription factor subunit RelA (Suppl. Fig. S1A)
(Gilmore, 2006). The assay was standardized by showing an increase in
nuclear RelA fluorescence following stimulation of NF-κB with 10 ng/
ml TNFα (Suppl. Fig. S1B). Fibroblasts in all senescence modes dis-
played significantly higher levels of nuclear RelA than the proliferating
control cells (Fig. 1A). Cellular ROS levels were measured by DHE
fluorescence. While we are aware that DHE fluorescence intensity is a
marker but not a quantitative measure of cytoplasmic superoxide, and
that cytoplasmic ROS originate from multiple sources including non-
mitochondrial ones, we have previously shown that the increase in ROS
markers associated with senescence can solely be attributed to mi-
tochondria (Correia-Melo et al., 2016). Therefore, we regard the
increase of DHE fluorescence above basal levels in senescent cells as a
simple indicator of SAMD. Accordingly, all senescent fibroblasts dis-
played increased DHE fluorescence (Fig. 1B) in accordance with earlier
data (Dalle Pezze et al., 2014; Passos et al., 2010, 2007). Treatment of
senescent cells for 2 days with the antioxidant catalase (CAT) depleted
intracellular ROS levels in senescent cells, but had little effect on the
low ROS levels in proliferating cells (Suppl. Fig. S2). Importantly, cat-
alase treatment completely rescued the senescence-associated activa-
tion of NF-κB (Fig. 1A), suggesting that SAMD-mediated ROS produc-
tion is necessary and sufficient for NF-κB activation in senescence. In
contrast, inhibition of NF-κB with the specific inhibitor, Bay 11-7082
(1 μM for 2 days) reduced NF-κB activation in senescent cells as ex-
pected (Suppl. Fig. S3), but had no effect on ROS levels (Fig. 1B), in-
dicating that the SAMD-mediated ROS hyper-production was in-
dependent from NF-κB signaling in all senescence modes. To
corroborate this finding, we stably over-expressed a dominant negative
NF-κB suppressor, ΔIκBα (Heimberg et al., 2001) in MRC5 fibroblasts
and grew them to replicative senescence. While this was effective in
suppression of TNFα-mediated NF-κB activation (Suppl. Fig. S1B), it
again did not diminish ROS production in senescent cells (Fig. 1C).
IL-6 and IL-8 are two important pro-inflammatory cytokines and
major components of the SASP in human fibroblasts. They are under
control of NF-κB, mediated partly via induction of IL-1 (Coppe et al.,
2008). However, other transcription factors, notably C/EBPβ, also de-
termine expression of these cytokines in senescence (Kuilman et al.,
2008). Thus, ROS might stimulate the SASP independently of NF-κB
activity. Therefore, we next assessed how NF-κB, IL- 1α and ROS de-
termined the amount of IL-6 and IL-8 secreted from senescent cells. As
expected, secretion of both IL-6 and IL-8 was enhanced in all modes of
fibroblast senescence (Fig. 1D). Interestingly, inhibition of NF-κB had
differential effects depending on senescence mode and interleukin
species: It was highly effective for both IL-6 and IL-8 in IR-induced
senescence (slightly less so for MRC5 than for IMR90) but resulted only
in a minor inhibition of secretion of both peptides in MRC5 replicative
senescence. In IMR90 + RAS, it was highly effective for IL-8 but did not
change IL-6 secretion at all (Fig. 1D). These data indicate variable roles
for signaling from the transcription factor NF-κB in SASP, depending on
senescence model and specific interleukin. To test whether this varia-
tion might arise at the level of IL-1α expression, we knocked down IL-
1α in two senescence models, MRC5-IR and IMR90 + RAS, which dif-
fered in their IL-6 and IL-8 response to inhibition of NF-κB (Fig. 1D).
Transfection with anti-IL1α siRNA reduced its mRNA (Suppl. Fig. S4A)
and protein levels (Suppl. Fig. S4B) similarly in both senescence modes.
It also impacted equally on IL-6 and IL-8 release in both forms of se-
nescence (Fig. 1E), suggesting that the different responses of these cy-
tokines to NF-κB inhibition are not mediated at or downstream of cy-
tokine IL-1α expression.
2.2. SAMD −induced SASP causes the senescent bystander effect
In co-culture with young, proliferation-competent fibroblasts, se-
nescent cells induce DNA damage that ultimately causes senescence in
the bystander cells (Nelson et al., 2012). To investigate the contribu-
tions of SASP and SAMD to the bystander effect, we established 2D co-
cultures of young MRC5 human diploid fibroblasts (bystanders) with
inducer fibroblasts rendered senescent in different modes (Fig. 2A).
Bystander cells were discriminated by expression of an mCherry-tagged
53BP1 which in young cells appear as diffuse nuclear red fluorescence
with only occasional bright foci, while it forms intense nuclear foci
upon induction of DNA damage (Nelson et al., 2009) and in senescence
(Passos et al., 2010). Already after 2 days of co-culture, ROS levels in
young bystander cells were enhanced and stayed above control levels
for the duration of the experiment, with levels comparable to senescent
cells (Suppl. Fig. S5). After 6 days of co-culture with inducer cells in any
senescence mode, young bystander cells displayed increased DDR
(Fig. 2B). Average frequencies of 53BP1 foci were significantly
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increased after co-culture with senescent, but not non-senescent in-
ducers (Fig. 2C), irrespective of the cell strain or the senescence mode
(Fig. 2C). A two way ANOVA with post hoc analysis indicated that there
was no significant difference between treatment cell line, with all se-
nescent inducers producing a significant increase in DDR compared to
their young inducer controls (either MRC5 or IMR90).
We next performed the co-culture experiments with MRC5-RS or
IMR90 + RAS as inducers in the presence of either the antioxidant
catalase or the NF-κB inhibitor Bay11-7082. After 6 days of co-culture,
the bystander effect from both types of senescence inducers was re-
duced by catalase, while the NF-κB inhibitor was able to suppress the
bystander effect of IMR90 + RAS, but not that of replicatively senes-
cent MRC5 inducers (Fig. 2D). This may be because Bay11-7082 sup-
presses IL-6 and IL-8 secretion from replicatively senescent MRC5 fi-
broblasts only weakly (see Fig. 1C). However, when the incubation of
bystander cells with replicatively senescent MRC5 fibroblasts was
prolonged to 21 days, NF-κB inhibition became as efficient in sup-
pression of the bystander effect as incubation with catalase (Fig. 2E).
Fig. 1. ROS controls SASP, but SASP does not
control SAMD. A: ROS release from senescent
cells is necessary for activation of NF-κB. Nuclear
and cytosolic localization of the NF-κB transcription
factor, RelA, was measured at single cell level by
immunofluorescence. Frequencies of cells with nu-
clear: cytosolic NF-κB signal ratio>1 are shown.
Cells were untreated (Ctrl) or treated with catalase
(100 U/ml for 2 days prior to fixation, +Cat).
Experiments were performed three times, data
shown are means +/− SD. Statistical tests were
performed as one way ANOVA with a Dunn's post-
hoc test. B: NF-κB activity does not impact on
senescence-associated ROS generation. Cultured
cells were grown with and without NF-κB inhibitor
(Bay11-7082, 1 μM) for 2 days prior to measuring
DHE fluorescence by flow cytometry. All modes of
senescence increased fluorescence intensity, but
there were no differences between cells treated with
the NF-κB inhibitor compared to their respective
controls. Each experiment was performed three
times, data shown are means +/− SD. Statistical
tests were performed as one way ANOVA with a
Dunn's post-hoc test. C: Transgenic inhibition of
NF-κB signalling does not affect ROS production
in replicative senescence. MRC5 transduced with a
lentiviral dominant negative IκBα −IRES-EGFP
construct were analysed as actively proliferating as
well as grown to replicative senescence for DHE
fluorescence by flow cytometry. Each experiment
was performed three times, data shown are means
+/− SD. Statistical tests were performed as a
Student's T-test (proliferating control versus Rep
Sen), and also as a one way ANOVA with parental
MRC5 cells (shown in B), which showed no sig-
nificant difference between the two replicatively se-
nescent populations. D: SASP cytokines are par-
tially controlled by NF-κB in replicative and
stress-induced senescence. ELISA measurements of
IL-6 (top) and IL-8 (bottom) in medium from cells as
indicated treated with and without NF-κB inhibitor
(Bay11-7082, 1 μM). Experiments were performed
twice (duplicate cultures ran in triplicate), data
plotted as mean +/− SD. Statistical tests were per-
formed as two way ANOVA with Holm-Sidak post-
hoc tests. E: IL-1α controls SASP cytokines in two
senescence modes. ELISA measurements of IL-6
(top) and IL-8 (bottom) in medium of cells 3 days
after transfection with IL-1α siRNA or scrambled
control siRNA. Experiments were performed twice
(duplicate cultures ran in triplicate), data plotted as
mean +/− SD. Statistical tests were performed
using a one way ANOVA with Holm-Sidak post-hoc
tests.
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Fig. 2. Role of SASP and SAMD for the bystander effect. A: Cartoon model representing the in vitro model system designed to analyse the senescent bystander effect. Three
different modes of cellular senescence were employed in the inducer cells: replicative senescence in MRC5 (Rep Sen), oncogene induced senescence via RAS in IMR90 (OIS), and X-ray
irradiation induced senescence (10 days post 20 Gy) of either MRC5 or IMR90 (IR). In each case, young proliferating MRC5 cells stably expressing mcherry-53BP1 were used as bystander
cells, cultured in a 1:1 ratio, and mcherry-53BP1 foci were counted in bystander cells to determine the level of DNA damage. B: Representative images of co-cultured bystander cells
(mCherry-53BP1 expressing MRC5) in the presence of inducer cells (MRC5 top, IMR90 bottom). The mode of senescence for each inducer type is shown in the image overlays. Dashed
outlines highlight inducer cell nuclei. Blue represents DAPI staining, red mCherry-53BP1. Note cytosolic autofluorescence present in senescent inducers. Scale bar = 10 μm. C: All modes
of senescence induce a bystander response. Co-cultures were grown for 7 days with either young proliferating control cells (Prolif.) or inducer cells in the indicated senescence mode.
53BP1 foci frequencies in the bystander cells are shown. Significant differences (* P < 0.05) in comparison to respective controls are indicated, Kruskal-Wallis ANOVA on Ranks with
Holm-Sidak post hoc test for pairwise comparison between groups. Neither cell strain nor senescence mode had a differential impact on the bystander effect (Two-way ANOVA test). Data
plotted are mean +/− SD from 100 to 150 cells per group from 3 independent replicates. D, E: ROS and NF-κB contribute to the bystander response. Proliferating control (Prolif or
−RAS) or senescent inducer cells as indicated were co-cultured with proliferating MRC5:53BP1 bystander cells in the presence of either Catalase (Antiox., 100U/ml), NF-κB inhibitor
Bay11-7082 (1 μM) or carrier (DMSO). Cultures were co-cultured for either 6 days (D) or 21 days (E). 53BP1 foci frequencies in the bystander cells are shown. CAT significantly inhibited
the bystander effect in all experiments, while Bay11-7082 reduced the bystander effect from MRC5-RS only after prolonged co-culture. Data plotted are mean +/− SD from 180 to 250
cells per group from 2 independent replicates. Kruskal-Wallis ANOVA on Ranks with Holm-Sidak post hoc test for pairwise comparison between groups, asterisks show P < 0.05. F:
ΔIκBα expression inhibits the bystander effect from replicatively senescent MRC5. Young (Prolif) or replicatively senescent (RS) MRC5 fibroblast stably transduced with either
mCherry or ΔIκBα we co-cultured with MRC5:53BP1 bystander cells. Differences between 53BP1 foci frequencies in bystander cells to those in proliferating cells alone are shown.
Experiments were performed in triplicate and between 60 and 120 cells were analysed per treatment and replicate. Data are mean ± SE (n = 3-5), with approximately 100 cells per
experiment. G: TNFα pre-stimulation enhances the bystander effect, and CAT abrogates it. Senescent inducer cells were stimulated with TNFα (TNF) or not (UNSTIM) before co-
culture with reporter cells for 21 days. CAT (ANTIOX) was added during co-culture. Differences between 53BP1 foci frequencies in bystander cells to those in proliferating cells alone are
shown. Data are mean ± SE (n = 3-5), with approximately 100 cells per experiment. H: Inhibitors of NF-κB, mTORC1 and p38MAPK equally suppress the bystander effect.
Replicatively senescent MRC5 fibroblasts were co-cultured with reporter cells for 21 days with either DMSO as carrier, Bay11-7082 (BAY), the mTORC1 inhibitor torin1 (TOR) or the
p38MAPK inhibitor UR-13756. Differences between 53BP1 foci frequencies in bystander cells to those in proliferating cells alone are shown. Data are mean ± SE (n = 3-5), with
approximately 100 cells per experiment. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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The long-term bystander effect from MRC5-RS fibroblasts was
equally inhibited by expressing the NF-κB super-repressor ΔIκBα in the
inducer cells only (Fig. 2F). Conversely, pre-treatment of senescent
inducer cells with TNFα before co-culture enhanced the bystander ef-
fect from wild-type, but not ΔIκBα− expressing inducers (Fig. 2G).
Catalase treatment was sufficient to rescue even this enhanced by-
stander effect (Fig. 2G).
Insufficient mitophagy is an important cause of mitochondrial dys-
function and ROS production in senescence, and activation of mito-
phagy by treatment with rapamycin improves mitochondrial function
and suppresses the pro-inflammatory SASP (Correia-Melo et al., 2016;
Dalle Pezze et al., 2014; Miwa et al., 2014). Accordingly, treatment of
co-cultured inducer and bystander cells with the specific mTORC1 in-
hibitor Torin1 was as efficient to suppress the bystander effect as
treatment with the NF-κB inhibitor Bay 11–7082 (Fig. 2H). The stress
response kinase p38/MAPK14 is a major intermediate for ROS-medi-
ated upregulation of NF-κB (Nakajima and Kitamura, 2013), and its
inhibition similarly suppressed the bystander effect (Fig. 2H).
Together these data suggest that in senescence, mitochondrial dys-
function induces ROS, which activate NF-κB via p38 and possibly other
pathways. This is responsible for the induction of a pro-inflammatory
SASP, albeit to different degrees in different cell types and/or modes of
senescence induction. SASP factors appear to be the main mediators of
cell-to-cell communication, transmitting the bystander effect.
3. Discussion
A recent series of intervention experiments has clearly pinpointed
senescent cells as an important cause of age-associated tissue dysfunc-
tion, (multi-)morbidity and, potentially, mortality (Baker et al., 2016;
Jurk et al., 2014; Ogrodnik et al., 2017; Roos et al., 2016; Schafer et al.,
2017; Zhu et al., 2015). Senescent cells impact on their tissue en-
vironment by a host of pathways: they secrete bioactive, especially pro-
inflammatory and matrix-degrading, peptides (the SASP, (Coppe et al.,
2008)), produce and release ROS as consequence of SAMD (Passos
et al., 2010, 2007), shed microvesicles that contain (relatively) specific
miRNAs (Weilner et al., 2016) and proteins (Effenberger et al., 2014)
and release modified lipids (Ni et al., 2016). These may act as signaling
molecules that spread senescence to bystander cells (Acosta et al., 2013;
Nelson et al., 2012), thus aggravating the pro-ageing effects of senes-
cent cells. While previous data are in agreement with the idea that SASP
factors might play a major role in induction of the senescent bystander
effect, other mediators have not been ruled out. In fact, effects from
conditioned medium were sometimes weak in comparison to cell–cell
contact or ROS-mediated effects (Nelson et al., 2012). Moreover, spe-
cific roles for individual SASP factors in transmission of the bystander
effect are not known.
To understand the interactions between SAMD and SASP in the
induction of bystander senescence, we examined the effects of scaven-
ging SAMD-dependent ROS or inhibiting the major SASP transcription
factor NF-κB in multiple modes of fibroblast senescence. It is known
that ROS can, in a context-depending manner, either activate or inhibit
NF-κB (Nakajima and Kitamura, 2013). Our results show that hyper-
production of ROS in senescence is driving NF-κB activation in all ex-
amined modes of senescence. Conversely, inhibition of NF-κB did not
change ROS hyper-production in senescence. This was unexpected as
earlier work showed that activation of NF-κB signaling by knockout of
the NFKB1 gene resulted in accelerated senescence and aggravated ROS
production in senescent cells (Jurk et al., 2014). The probable ex-
planation for this discrepancy lies in the existence of multiple pathways
leading to ROS production in senescent cells: the DNA Damage Re-
sponse drives SAMD and thus increases ROS to a level that is necessary
to establish senescence (Passos et al., 2010); activation of NF-κB in-
creases ROS further by pathway(s) that involve cyclooxygenase acti-
vation among others, but not enhancement of mitochondrial ROS pro-
duction (Jurk et al., 2014). Thus, SAMD activates NF-κB via ROS but is
not targeted by NF-κB activity, although NF-κB activation contributes to
non-mitochondrial ROS production. This interpretation is supported by
data showing that the pro-inflammatory SASP is suppressed in those
modes of senescence where mitochondrial dysfunction does not lead to
enhanced cytoplasmic (and presumably nuclear) ROS levels (Wiley
et al., 2016). In phagocytes, mitochondrial ROS production and NF-κB
activation are interconnected by formation of a complex between mi-
tochondrial complex I–evolutionarily conserved signaling intermediate
in Toll pathways (ECSIT) and the ubiquitin ligase tumor necrosis factor
receptor-associated factor 6 (TRAF6) (Min et al., 2017; West et al.,
2011). Whether this complex is also activated in fibroblasts senescence
is not clear yet.
NF-κB is not the only transcription factor driving the pro-in-
flammatory arm of the SASP (Acosta et al., 2008). Our data show that
its impact on secretion of the two major pro-inflammatory cytokines, IL-
6 and IL-8, significantly depends on cell type, senescence mode and
specific cytokine. In MRC5 replicative senescence, for instance, the
impact of NF-κB signaling on IL-6 and IL-8 secretion was significant but
rather small (Fig. 1D). In contrast, a number of interventions were all
similarly effective in blocking the senescence-induced induction of a
DDR in bystander MRC5 fibroblasts. Although the antioxidant reduced
the bystander response earlier than the NF-κB inhibitor, both were able
to rescue the bystander effect completely after prolonged incubation,
and this was not different from inhibition of signaling through mTORC1
or p38MAPK. We interpret these results as follows:
ROS hyper-production in senescence is at least partially due, or
aggravated by, accumulation of dysfunctional mitochondria, which in
turn is mediated by a failure of mitophagy (Dalle Pezze et al., 2014;
Korolchuk et al., 2017). SAMD can be rescued by inhibition of mTORC1
signalling using rapamycin (Correia-Melo et al., 2016) or torin (Dalle
Pezze et al., 2014), activating autophagy. ROS signal through p38MAPK
to activate NF-κB in senescent cells, and NF-κB in turn is responsible for
some, but not all of the SASP. The fact that, given sufficiently long
incubation, inhibitors for all tested components of this pathway effec-
tively and completely rescued the bystander response suggest that
peptides transcribed under control of NF-κB are the intercellular med-
iators of the senescent bystander response. However, neither IL-6 nor
IL-8 seem to play major roles in this respect, as they are only to a small
degree controlled by NF-κB in senescent MRC5 fibroblasts. Further
work will be necessary to identify more potent intercellular signal
transducer candidates for the senescent bystander effect.
4. Materials and methods
4.1. Cell culture
Proliferating cells. Embryonic human lung fibroblasts MRC5 were
from ECACC. MRC5-mCherry-53BP1 cells were created as described
previously (Hewitt et al., 2016). Cells were cultured in DMEM (Sigma
Aldrich) supplemented with 10% foetal calf serum (Sigma Aldrich),
100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM l-Glutamine at
20% oxygen, 5% CO2 at 37 °C. Embryonic lung fibroblast IMR90 were
cultured in phenol-free DMEM with supplements as above at 3%
oxygen, 5% CO2, 37 °C. Stably transfected IMR90ER:RAS (a gift from
Peter Adams) were cultured in the same manner as the parental IMR90
plus 300 μg/ml G418 selection at 3% oxygen, sub-cultured every third
day.
The NF-κB super-repressor vector pLenti-ΔIκBα-IRES-EGFP was
created by first cloning IκΒα minus the first 40 amino acids from pIκB-
EGFP (Clontech), into the MCS of pIRES2-EGFP (Clontech) and then the
entire ΔIκBα-IRES-EGFP cassette into the expression site of pLenti6-
UbC-V5DEST. Young (PD<x +25) MRC5 were transduced with viral
particles produced in Hek293FT cells using Virapower packaging mix as
per the manufacturer's instructions (Life Technologies) and selected for
6 days with Blasticidin before utilisation.
Senescent cells. To generate replicatively senescent cells (MRC5
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RepSen), MRC5 cells were cultured in complete medium at 20%
oxygen, passaging before confluency, until PD < 0.1 per month. Stress
induced senescent MRC5 (MRC5 IR) and IMR90 (IMR90 IR) were cre-
ated by X-ray irradiation. 6300 cells/cm2 were seeded 24 h prior to
20 Gy irradiation and were used for experiments 7 days later.
Oncogene-induced senescent cells (IMR90 OIS) were used on day 7
after induction of RAS overexpression in IMR-90ER:RAS by incubation
with 100 nM 4-hydroxy-tamoxifen (4OHT).
For direct co-culture experiments, inducer senescent cells were
plated at 5500 cells/cm2 density either on glass cover slips (No. 1.5) in
12 well plates or in 35 mm glass bottomed dishes (Willco) for live cell
microscopy. Twenty four hours later, young bystander cells were plated
in 1:1 ratio and co-cultures were maintained for 6 days. For treatment
with chemical inhibitors: 1 μM Bay 11–7082, 10 nM Torin1, 1 μM UR-
13756 (Bagley et al., 2010) or 100 U/ml catalase or DMSO as a control
were added 24 h post seeding of bystanders and re-freshed every
3 days. TNFα was used at 10 ng/ml. Pre-treatment of inducer cells with
TNFα was performed for 1 h before replacing with fresh medium and
seeding bystander cells.
Treatment with siRNA was performed 24 h after seeding of by-
stander cells. Co-cultures were transfected using 5 nM Silencer select
Pre-designed siRNA and Lipofectamine™ RNAiMAX (Thermo Fisher) in
antibiotic-free medium. Forty-eight hours later, transfections were re-
peated and cells were fixed after 6 days in co-culture.
4.2. Detection of ROS
ROS production was assessed in cultured fibroblasts by staining
trypsinised cells with 10 μM Dihydroethidium (DHE) and measuring
fluorescence by flow cytometry as described previously (Dalle Pezze
et al., 2014). For measurement of co-cultured cells, DHE fluorescence
was measured by live cell microscopy to robustly separate young by-
standers from senescent inducers (see Microscopy section below).
4.3. ELISA assays
Cells were incubated in fresh half normal volume of media for 40 h
prior to collection. Samples were cleared by centrifugation for 10 min
at 4 °C at 8000g and then concentrated 2 times by Cryospin. Protein
concentration was measured using DC Protein assay (BioRad) according
to the manufacturer's protocol. Concentrated conditioned media were
assessed using the respective Sandwich ELISA DuoSet Development
System kits (R & D Systems, Abingdon, UK). The kits were tested and
suitably modified to be transferred onto a 384-well plate platform with
the use of an EpMotion 5075 Liquid Handling robot. All colorimetric
measurements were performed at 450 nm with wavelength correction
at 550 nm on an Omega microplate reader (BMG Labtech, Aylesbury,
UK) applying a four-parameter logistic curve fit to the respective
standard curves. Data were normalized to total protein concentrations.
4.4. Microscopy
For end point analysis of mCherry fluorescence, cells were fixed for
10 min with 4% PFA and mounted using Prolong Diamond Antifade
with DAPI (Thermo Fisher, UK), or were imaged by live cell micro-
scopy.
For immunofluorescence, cells were fixed as above and incubated
with rabbit anti-p65 (1:400, Cell Signalling) overnight at 4oC. For vi-
sualization of the staining, AlexaFluor 488 conjugated secondary anti-
body was used (Thermo Fisher).
Imaging was performed using a Zeiss Spinning Disk Confocal
system, coupled with Quant-EM 512 SC camera (Photometrics) and
Yokogawa CSU-X1 spinning disk head, with a 63 x (NA 1.4) objective,
and a temperature and gas regulated incubator (Pecon). Image acqui-
sition was via AxioVision software (Zeiss, UK) and image analysis
(counts of mCherry DNA damage foci per nucleus, and RelA nuclear and
cytosolic fluorescence intensities) was performed in ImageJ. To ensure
accurate comparisons, all imaging within an experiment was performed
using the same excitation intensities, exposure times and objectives.
Also, to improve quantification, mean nuclear RelA fluorescence was
normalised to the cells respective cytosolic RelA fluorescence staining.
This removes any differences from staining variability from coverslip to
coverslip, or any slight differences in focal plane or laser intensity from
field to field. Population-level activation rates were determined by
measuring the percentage of cells per field that had predominantly
nuclear (i.e. nuclear: cytosolic fluorescence ratio of RelA staining
was> 1 per cell) RelA fluorescence.
For measurement of DHE fluorescence by live cell microscopy,
MRC5 cells stably transduced with an EGFP-luc expression cassette
(pSLIEW) were used as bystanders to identify them from the senescent
parental line MRC5 inducers based upon nuclear EGFP fluorescence.
Cells were plated as described above and stained with DHE as for flow
cytometry measurements, then washed and replaced with Fluorobrite
medium (Thermo Fisher) plus 10% FCS. Staining was performed in a
serial manner to maintain the same incubation times per dish. Images
were captured using a DMi8 widefield fluorescence microscope
equipped with a 20 × 0.8NA objective, a Sola-SE LED light source
(Lumencor) and a Flash4 sCMOS camera (Hamamatsu) using LASX
software (Leica). EGFP, DHE and brightfield images were captured for
each field using GFP and TX2 filter cubes (Leica) for the fluorescent
channels representing EGFP and DHE respectively. Mean nuclear DHE
fluorescence (from TX2 filterset) was determined using ImageJ for at
least 100 cells from 3 different dishes per group, using the brightfield
image to identify the nucleus. Intensities were background subtracted
based upon mean+ 2xSD nuclear fluorescence intensity from TX2
images of young EGFP expressing cells without any DHE staining. In co-
cultured dishes, bystander cells were identified by EGFP expression
being present throughout the cell (using the GFP filterset image), and
were identified by their nuclear EGFP fluorescence to allow dis-
crimination from lipofuscin-based autofluorescence, visible in the cy-
tosol of the senescent inducer cells.
4.5. Statistical analysis
All analysis was performed using SigmaPlot 12.5 software, using
one-way ANOVA test (parametric data) or Kruskal-Wallis ANOVA (non-
parametric). Post-hoc tests were performed pairwise within datasets
using Dunn’s or Holm-Sidak method. Cut-off of significance was set at
p < 0.05 (denoted as * in Figures). Two-way ANOVA test was used for
assessment of the relationship between cell line background and mode
of senescence or treatments.
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